6505--Levothyroxine Tablets (VA-24-00084562)
ID: 36E79724R0020Type: Solicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/e6a814ab06ae460dbb42e7e9d9c3b52c/view
Timeline
    Description

    The Department of Veterans Affairs is seeking suppliers for Levothyroxine Tablets under the solicitation titled '6505--Levothyroxine Tablets (VA-24-00084562)'. This procurement aims to acquire pharmaceutical preparations, specifically Levothyroxine, which is critical for treating thyroid hormone deficiencies in veterans. The contract will fall under the NAICS code 325412, which pertains to Pharmaceutical Preparation Manufacturing, and the PSC code 6505, indicating Drugs and Biologicals. Interested vendors can reach out to Contract Specialist Youlanda Duggar at youlanda.duggar@va.gov for further details regarding the submission process and deadlines.

    Point(s) of Contact
    Youlanda DuggarContract Specialist
    youlanda.duggar@va.gov
    Files
    Title
    Posted
    _rels/.rels
    [Content_Types].xml
    36E79724R0020_1.docx
    The Department of Veterans Affairs (VA) plans to solicit proposals for the supply of Levothyroxine Sodium Tablets (RFP 36E79724R0020). This procurement aims to ensure an uninterrupted supply of these tablets for various VA facilities and services, including Consolidated Mail Order Pharmacies, State Veterans Homes, the Indian Health Service, and the Federal Health Care Center. The contract will span one year, with four additional pre-priced option periods. Offerors must provide specific product samples and adhere to packaging requirements, including safety features and label specifications. The estimated annual demand across 12 dosage variations totals over one million tablets. Interested suppliers must monitor SAM.gov for updates and submit proposals by September 30, 2024. The point of contact for inquiries is Youlanda Duggar, who can be reached via email or phone. This solicitation reflects the VA's commitment to meeting the pharmaceutical needs of veterans through a structured procurement process.
    docProps/app.xml
    docProps/core.xml
    word/_rels/document.xml.rels
    word/document.xml
    word/fontTable.xml
    word/footer1.xml
    word/footer10.xml
    word/footer11.xml
    word/footer12.xml
    word/footer13.xml
    word/footer14.xml
    word/footer15.xml
    word/footer16.xml
    word/footer2.xml
    word/footer3.xml
    word/footer4.xml
    word/footer5.xml
    word/footer6.xml
    word/footer7.xml
    word/footer8.xml
    word/footer9.xml
    word/header1.xml
    word/header10.xml
    word/header11.xml
    word/header12.xml
    word/header13.xml
    word/header14.xml
    word/header2.xml
    word/header3.xml
    word/header4.xml
    word/header5.xml
    word/header6.xml
    word/header7.xml
    word/header8.xml
    word/header9.xml
    word/numbering.xml
    word/settings.xml
    word/styles.xml
    word/theme/theme1.xml
    word/webSettings.xml
    Lifecycle
    Title
    Type
    6505--Levothyroxine Tablets (VA-24-00084562)
    Currently viewing
    Solicitation
    6505--Levothyroxine Tablets (VA-24-00084562)
    Presolicitation
    Similar Opportunities
    6505--Norethindrone 5mg Tablet (VA-25-00005551)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking to procure Norethindrone 5mg Tablets under solicitation number VA-25-00005551. This procurement falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized as drugs and biologicals, indicating the importance of these tablets in the healthcare services provided to veterans. Interested vendors should reach out to the primary contact, Contracting Officer Adrienne A Albachiara, via email at Adrienne.Albachiara@va.gov for further details regarding the submission process and any deadlines associated with this opportunity.
    6505--Prasugrel HCL 5mg and 10mg 30 Count Bottles
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Prasugrel Hydrochloride (HCL) tablets in 5mg and 10mg 30 count bottles. The procurement aims to establish a reliable supply chain for these pharmaceutical products, which are critical for the healthcare of veterans and related agencies, ensuring compliance with federal regulations and the Drug Supply Chain Security Act (DSCSA). Offerors must provide pricing for a base year and four optional one-year periods, demonstrate manufacturing and distribution capabilities, and adhere to stringent reporting and safety standards. Interested contractors should contact Contract Specialist Matthew S. Poulin at Matthew.Poulin@va.gov for further details regarding the solicitation process.
    6505--Zolmitriptan Tablets (VA-25-00006129)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Zolmitriptan tablets, as outlined in solicitation number VA-25-00006129. This contract aims to establish a reliable source of pharmaceutical supplies for federal healthcare programs, emphasizing compliance with the Drug Supply Chain Security Act (DSCSA) and good manufacturing practices as mandated by the FDA. The selected contractor will be responsible for providing competitive pricing for both the base year and four option years, ensuring that all products meet safety and regulatory standards. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details and to discuss submission requirements.
    6505--Abiraterone Acetate Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting offers for the supply of Abiraterone Acetate tablets, a pharmaceutical product critical for various government healthcare facilities, including the VA and DoD. The procurement aims to establish a reliable source through competitive contracting, requiring offerors to provide pricing for a base year and four option years, along with an NDC number for their products. Abiraterone Acetate is essential for treating specific cancers, underscoring the importance of ensuring consistent availability of this medication to support patient care. Interested vendors should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must comply with specific packaging, labeling, and manufacturing standards as outlined in the solicitation document.
    6505--Bupropion Tablets
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting proposals for the procurement of Bupropion Hydrochloride tablets, aimed at supporting veterans and related entities through its Pharmaceutical Prime Vendor Programs. Offerors are required to submit pricing that includes a 0.5% Cost Recovery Fee and provide unique National Drug Code (NDC) numbers for their products, while ensuring compliance with the Drug Supply Chain Security Act (DSCSA) and FDA regulations. This procurement is crucial for maintaining a reliable pharmaceutical supply for VA healthcare facilities, with an emphasis on participation from small and disadvantaged businesses. Interested parties can reach out to Contract Specialist Andrew J. Cazares at Andrew.Cazares@va.gov for further details.
    6505--763-24-3-021-1011 -Lancaster CMOP CLOMIPHENE CITRATE -(VA-24-00076661)
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified vendors to supply Clomiphene Citrate 50mg tablets for delivery to the Lancaster Consolidated Mail Outpatient Pharmacy (CMOP) facility in Texas. The procurement involves a requirement for 480 units of the specified pharmaceutical, with a focus on compliance with the Drug Supply Chain Security Act and other federal regulations. This opportunity is particularly significant as it supports the VA's commitment to ensuring a reliable supply of essential medications for veterans while promoting small business participation in federal contracting. Interested suppliers must submit their quotations, including a signed solicitation cover page, a completed price schedule, a valid State Wholesale Distributor License, and a Buy American Act certificate by September 17, 2024, at 3:00 PM Central Time. For further inquiries, vendors can contact Kelley Cunningham at Kelley.Cunningham@va.gov or call 913-684-0140.
    6505--Lymphoseek IDIQ
    Active
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, specifically the Network Contracting Office 22, intends to award a Sole Source contract for the procurement of Lymphoseek, a proprietary radiopharmaceutical, primarily for use at the VA Loma Linda Healthcare System. This contract, designated as Solicitation Number 36C26225Q0026, will be structured as a Firm Fixed-Price Indefinite Quantity Indefinite Delivery (IDIQ) with a base year and four option years, with an estimated quantity of 86 study doses required annually. Lymphoseek is critical for identifying sentinel lymph nodes in melanoma patients, providing superior image quality due to its targeted action on the CD206 receptor. Interested parties may submit a capabilities statement by September 27, 2024, at 10:00 AM Pacific Time, and should direct inquiries to Hestia Sim at Hestia.Sim@va.gov.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used for treating high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. Interested parties can contact Catherine Gilbert for more information. The solicitation is projected to be issued in December 2019.
    PRAVASTATIN SODIUM TABLETS
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Pravastatin Sodium tablets. The tablets are available in 10MG, 20MG, and 80MG strengths, and will be packaged in bottle counts of 90 and 1000. This contract will establish a national supply source to provide the tablets for purchase by Department of Defense, Bureau of Prisons, Indian Health Service, and Department of Veterans Affairs customers. The contract will be a firm-fixed price, requirements type contract with a one-year base and four one-year options. The solicitation is expected to be posted in January 2019.
    Valsartan
    Active
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.